Veteran-Owned NJF Worldwide: Authorized Distributor of the First & Only FDA-Cleared Rapid Fentanyl Urine Test Cassette
AllTest™ Fentanyl Rapid Test
The only FDA 510(k) Cleared Fentanyl Test
Authorized Distributor of AllTest™ Rapid Fentanyl Urine Test Cassette
ADL’s available upon request
Point-of-Care
At-Home
Product Advantages
Discover the Benefits. Our Fentanyl Rapid Tests Lead the Way.
High Accuracy
Ensure precision with our fentanyl rapid tests, delivering reliable results for confident and accurate detection.
Fast Results in 5 Minutes
Swift and dependable – our fentanyl rapid tests provide rapid results within just 5 minutes, enabling prompt decision-making.
Easy Visual Interpretation
Simplifying the process, our rapid tests offer clear visual cues for straightforward fentanyl detection, ensuring ease of interpretation.
Easy Specimen Collection
Streamline the testing process with hassle-free specimen collection, making it convenient and straightforward for accurate fentanyl screening.
Convenient Procedure
Experience convenience with our user-friendly fentanyl rapid tests, designed for a seamless testing procedure that fits effortlessly into your routine.
Lower Cut-Off (1ng/ml)
Elevate your standards with a lower cut-off of 1ng/ml, enhancing sensitivity for early and precise detection of fentanyl in urine screenings.
The FACTS About Fentanyl
Get the facts with the statistics below.
- Fentanyl is a highly addictive synthetic opioid that is 50 times more potent than heroin and 100 times more potent than morphine.
- Just two milligrams of fentanyl (the small amount that fits on the tip of a pencil) is considered a potentially deadly dose.
- According to the CDC, 107,622 Americans died of drug poisoning in 2021, with 75% of those deaths involving synthetic opioids like fentanyl.
- In 2022, fentanyl was responsible for 200 deaths every day. Over a quarter of a million Americans have died from a fentanyl overdose since 2018.
- According to the CDC, 107,622 Americans died of drug poisoning in 2021, with 75% of those deaths involving synthetic opioids like fentanyl.
- In 2022, fentanyl was responsible for 200 deaths every day. Over a quarter of a million Americans have died from a fentanyl overdose since 2018.
- Fentanyl is involved in more deaths of people under 50 than any other cause -even heart disease, cancer, homicide, and suicide.
- In the past two years, the number of teenage overdose fatalities associated with opioids such as fentanyl has tripled.
Despite these shocking statistics, only 5% of individuals experiencing overdoses in the hospital emergency rooms undergo testing for Fentanyl! We know the problems, let's focus on finding solutions!
Benefits of AllTest Rapid Fentanyl Test
Alltest is the only FDA Cleared Rapid Fentanyl Urine Test on the market!
Performance
Sensitivity
Specificity
Accuracy
Common Misconceptions
While fentanyl is extremely potent, not every exposure or use leads to death. The risk of overdose increases significantly when it is used inappropriately or mixed with other substances.
While standard drug tests are effective for detecting certain substances, they may not reliably identify trace amounts of fentanyl. Fentanyl requires specific testing methods, and relying solely on multi-drug tests or testing strips designed for general opioid detection can lead to inaccuracies.
Fentanyl can also be encountered unintentionally, such as in counterfeit medications, through everyday vapes or when mixed with other drugs. It poses a risk to individuals who may not be aware of its presence, emphasizing the need for caution across various substances.
The risk of overdosing on fentanyl through touching a contaminated object is extremely low. Harmful exposure usually requires direct ingestion, inhalation, or injection, dispelling the notion of a significant overdose risk from casual contact.
Funding, Trends & Current Market Demand
- Opioid Settlement Fund: Established with over $56 billion to address the lega laftermath of the opioid epidemic. Supports state/local governments by covering healthcare costs, addiction treatment and testing initiatives to combat the crisis.
- Growing Market Size: Global fentanyl market to reach USD 28 billion by 2035with a 6% CAGR.
- Increasing Healthcare Spending: Rising global healthcare spending expected to boost the fentanyl market.
- Demand for Point-of-Care Opioid Testing: Projected growth to US$ 725.1million (2033) driven by the opioid epidemic and testing advancements.
- Expansion into Non-Traditional Settings: Point-of-Care opioid testing extends to workplaces, home care and telehealth, creating new market opportunities.
Frequently Asked Questions
Learn what we are asked about the most below.
Why is there a need for an over-the-counter rapid fentanyl detection test in big box and retail stores?
The necessity for an over-the-counter rapid fentanyl detection test in big box and retail stores is critical in confronting the escalating opioid crisis nationwide. Fentanyl, a potent synthetic opioid, is a major factor in the surge of overdose cases. By providing rapid detection tests like the Alltest Rapid Fentanyl Urine Cassette, these stores play a pivotal role in enabling individuals and families to test for fentanyl presence quickly, which is key to ensuring safety and proactive health measures.
How does the community as a whole benefit from the availability of rapid fentanyl detection tests?
The community benefits immensely from the availability of rapid fentanyl detection tests. These tests offer a fast and reliable way to detect fentanyl, helping to reduce accidental overdoses. Their widespread availability also enhances public awareness of the dangers of fentanyl and the broader opioid crisis, promoting a more informed and health-conscious community. Additionally, their presence can act as a deterrent against the use of fentanyl-laced substances, contributing to a decrease in their demand and overall community safety.
Why is NJF Worldwide LLC’s role as the authorized distributor of the Alltest Rapid Fentanyl Urine Cassette significant?
NJF Worldwide LLC, as the authorized distributor of the Alltest Rapid Fentanyl Urine Cassette, plays an essential role in ensuring public access to a reliable and effective fentanyl detection method. As a service-disabled veteran-owned and minority-owned business, NJF Worldwide LLC not only facilitates the distribution of this crucial health tool but also supports government agencies and corporate companies in achieving their diversity and inclusion objectives. Their involvement is key in the widespread distribution of a critical fentanyl detection tool.
What sets the Alltest Rapid Fentanyl Urine Cassette apart from other fentanyl detection methods?
The Alltest Rapid Fentanyl Urine Cassette stands out for its ability to detect fentanyl with a high sensitivity rate of 1ng/ml and within a remarkably quick time frame of five minutes from collecting the specimen. This level of sensitivity and speed is unparalleled in the market, ensuring that even minimal traces of fentanyl can be detected efficiently, which is crucial for overdose prevention and exposure reduction. Furthermore, this test is the only FDA-approved, over-the-counter fentanyl urine detection method and is listed on the FDA’s 510(K) list, reinforcing its reliability and trustworthiness. This combination of speed, sensitivity, and regulatory approval makes it a top choice for both individuals and healthcare professionals.
How would a rapid OTC urine test to detect fentanyl in an individual's system have distinct applications and benefits for large retail chains, compared to test strips used on substances?
Applications:
- Employee screening: While not a substitute for professional drug testing, an OTC urine test could offer a preliminary, non-invasive option for large retailers to screen employees potentially at risk of handling fentanyl-contaminated products.
- Enhanced security measures: Identifying employees under the influence of fentanyl could inform security protocols and prevent potential threats to employee or customer safety.
- Supporting employee well-being: Offering confidential access to OTC urine tests could encourage employees struggling with substance abuse to seek help discreetly, promoting a culture of support and wellness.
- Customer outreach and risk assessment: Discreetly providing OTC urine tests in designated areas could offer customers concerned about potential fentanyl exposure a means to assess their personal risk anonymously. This could encourage them to seek medical attention or harm reduction resources.
What are the Benefits for large retail chains?
- Proactive risk management: Early detection of fentanyl exposure among employees can minimize security risks and potential accidents.
- Demonstration of care and responsibility: Providing access to these tests signals a commitment to employee well-being and customer safety, potentially enhancing brand image.
- Potential cost savings: Addressing substance abuse issues among employees can mitigate risks of workplace accidents, theft, and absenteeism.
- Public health contribution: Increased access to testing options could contribute to broader public health efforts by encouraging responsible drug use and facilitating access to treatment resources.
Who are some of the main customers and markets for ALLTEST OTC URINE CASSETTES?
ALLTEST IS THE ONLY FDA APPROVED RAPID FENTANYL URINE TEST ON THE MARKET!
- Personal Home Use
- Student Testing
- Non-Profit Organizations
- Pre-Employment Screening
- Random Drug Testing
- Court Ordered Testing
- Counseling and Support Groups
- CDC, OEM, EMS, HHS and More!
- Fair Market Retail and Wholesalers
- Medical supply companies
- OSHA
- Unions
- Community outreach programs
Who would be the main customer/market for ALLTEST Rx URINE CASSETTES?
- Court Ordered Testing
- CDC, OEM, EMS, HHS
- Healthcare Facilities
- Law Enforcement Agencies
- Social Services Agencies
- Correctional Facilities
- Treatment Centers
- Methadone Clinics
- Probation Services
- Military Organizations
- Employee Drug Testing (OSHA)
- Harm Reduction Organizations
- Schools/Universities And More!